Skip to main content
. 2019 Aug 30;19(17):3762. doi: 10.3390/s19173762

Figure 2.

Figure 2

Multiplexed electrochemical sensor in connection with EFIRM technology for the determination of EGFR mutations in bodily fluids of patients with lung cancer. Reprinted from [21] with permission.